此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

ESPB 与 iPACK+ACB 在全膝关节置换术中的比较

2026年11月4日 更新者:Poznan University of Medical Sciences

竖脊肌平面阻滞与带有内收肌管阻滞的 iPACK 阻滞对比,用于全膝关节置换术患者的疼痛管理

Effect of iPACK block with Adductor Canal Block and ESPB on pain management, and NLR and PLR following knee arthroplasty

研究概览

详细说明

Knee arthroplasty is one of the most common orthopaedic procedures, especially in elderly patients, due to the deformation of joints. Patients may complain of severe pain due to surgical trauma and prostheses. Regional anaesthesia methods may be performed to reduce the surgery's induced stress response, opioid consumption, and opioid-related side effects.

In recent years, the influence of regional anesthesiology on reducing the inflammatory response after surgical procedures has been emphasised. However, very few studies have evaluated the effect of various methods of anaesthesia on the NLR and PLR.

This is the first study to investigate the effect of regional anaesthesia on the pain managementonse expres and stress respsed by the NLR and PLR in patients undergoing knee replacement surgery.

研究类型

介入性

注册 (实际的)

60

阶段

  • 第四阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Poznań
      • Poznan、Poznań、波兰、61-701
        • Poznan University of Medical Sciences

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 100年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Patients with ASA classification I-III, Aged 20-90 years, Who will be scheduled for knee arthroplasty under spinal anaesthesia.

Exclusion Criteria:

  • patients who have a history of bleeding diathesis,
  • take anticoagulant therapy,
  • have a History of chronic pain before surgery,
  • have Multiple trauma, cannot assess their pain (dementia),
  • have been operated on under general anaesthesia,
  • have an infection in the area and do not accept the procedure

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
有源比较器:iPACK + ACB

spinal anesthesia

+ ultrasound guided iPACK (20ml 0,2% ropivacaine) with ACB (10ml 0.5% ropivacaine)

iPACK block + Adductor Canal Block

其他名称:
  • iPACK + ACB

Erector Spinae Plane Block

其他名称:
  • ESPB
有源比较器:Erectro Spinae Plane Block

spinal anesthesia

+ ultrasound guided ESPBk - 20ml 0,2% ropivacaine

iPACK block + Adductor Canal Block

其他名称:
  • iPACK + ACB

Erector Spinae Plane Block

其他名称:
  • ESPB
安慰剂比较:Control group

Only spinal anesthesia - No peripheral nerve block

only spinal anesthesia

其他名称:
  • 仅脊髓麻醉

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Opioid consumption
大体时间:48 hours after surgery

Total opiate consumption after surgery

48 hours after surgery

次要结果测量

结果测量
措施说明
大体时间
Time to first rescue opiate analgesia
大体时间:48 hours after procedure

Time after surgery when the patient needs opiate for the first time

48 hours after procedure
Numerical Rating Scale [range 0:10]
大体时间:Time Frame: 4 hours after surgery

Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)

Time Frame: 4 hours after surgery
Numerical Rating Scale [range 0:10]
大体时间:Time Frame: 8 hours after surgery

Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)

Time Frame: 8 hours after surgery
Numerical Rating Scale [range 0:10]
大体时间:Time Frame: 12 hours after surgery

Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)

Time Frame: 12 hours after surgery
Numerical Rating Scale [range 0:10]
大体时间:Time Frame: 16 hours after surgery

Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)

Time Frame: 16 hours after surgery
Numerical Rating Scale [range 0:10]
大体时间:Time Frame: 20 hours after surgery

Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)

Time Frame: 20 hours after surgery
Numerical Rating Scale [range 0:10]
大体时间:Time Frame: 24 hours after surgery

Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)

Time Frame: 24 hours after surgery
Numerical Rating Scale [range 0:10]
大体时间:Time Frame: 36 hours after surgery

Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)

Time Frame: 36 hours after surgery
Numerical Rating Scale [range 0:10]
大体时间:Time Frame: 48 hours after surgery

Postoperative pain assessment will be performed using the NRS score (0 = no pain, 10 = the most severe pain felt)

Time Frame: 48 hours after surgery
Neutrophil-to-lymphocyte ratio
大体时间:24 hours after surgery

Neutrophil-to-lymphocyte ratio

24 hours after surgery
Neutrophil-to-lymphocyte ratio
大体时间:48 hours after surgery

Neutrophil-to-lymphocyte ratio

48 hours after surgery
Platelet-to-lymphocyte ratio
大体时间:24 hours after surgery

Platelet-to-lymphocyte ratio

24 hours after surgery
Platelet-to-lymphocyte ratio
大体时间:48 hours after surgery

Platelet-to-lymphocyte ratio

48 hours after surgery
Quadriceps muscle strength assessed using medical research council scale [range 0:5]
大体时间:Postoperative 24 hours period

Quadriceps muscle strength (knee extension and hip adduction) will be evaluated according to the medical research council muscle strength rating

Postoperative 24 hours period

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 学习椅:Łukasz Łapaj, Ph.D.、Poznań University of Medical Sciences

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2024年3月8日

初级完成 (实际的)

2024年8月16日

研究完成 (实际的)

2025年9月16日

研究注册日期

首次提交

2024年3月4日

首先提交符合 QC 标准的

2024年3月4日

首次发布 (实际的)

2024年3月8日

研究记录更新

最后更新发布 (实际的)

2026年11月6日

上次提交的符合 QC 标准的更新

2026年11月4日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

Please provide the plan description

IPD 共享时间框架

6 month after study completion

IPD 共享访问标准

from the corresponding author on the resonable request

IPD 共享支持信息类型

  • 研究方案
  • 树液
  • 国际碳纤维联合会
  • 分析代码
  • 企业社会责任

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅